Clinical trial
A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients…
NCT00172016 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00172016 |
|---|---|
| Title | A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates |
| Official title | A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Prostate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated |
| Intervention type | Drug |
| Interventions | Zoledronic acid |
| Enrollment | 43 |
| Start date | Jan 1, 2004 |
| Primary completion | Apr 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 30, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: